NPPB and hydrops fetalis: While predicted trajectory did not improve HF risk prediction beyond NT‐proBNP, suggesting this biomarker may be sufficient for predicting HF risk, NT‐proBNP alone is not able to distinguish the underlying cardiac dysfunction (systolic, diastolic, both) or the type of incident HF (HFpEF vs. HFrEF).